Oral Disintegrating Strip Market
Oral Disintegrating Strip Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Oral Disintegrating Strip Market Size and Growth
The Oral Disintegrating Strip market is experiencing significant growth, driven by increased demand for convenient drug delivery. The global market size was valued at approximately $4 billion in 2023, with an expected CAGR of around 8% over the next five years. Key factors include innovation, rising prevalence of chronic diseases, and consumer preferences for non-injection medications.
Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Aavishkar
◍ ZIM Laboratories
◍ Cure Pharmaceutical
◍ Umang
◍ LLS Health
◍ LIVKON Pharmaceutical Pvt Ltd
◍ IntelGenx Corp.
◍ Arx Pharma
◍ Aquestive Therapeutics
◍ NAL Pharma
◍ Adhex Pharma
◍ Tapemark
◍ Top Pharm
◍ J&J
◍ Shilpa Therapeutics
◍ BioDelivery(BDSI)
◍ Lohmann Therapie-Systeme
The Oral Disintegrating Strip market is competitive, driven by innovation and convenience. Companies like Aavishkar, Cure Pharmaceutical, and Aquestive Therapeutics enhance market growth through product development and strategic partnerships. Key players focus on improving drug delivery, expanding applications, and increasing accessibility, driving sales and market presence. Actual sales figures are not disclosed.
◍ QQP
Request Sample Report
Market Segmentation
By Application
By Product
Healthcare Type ◍ Hospital and Clinic ◍ Supermarket and Drug Store ◍ E-commerce
Others
Request Sample Report
Therapeutic Type
Market Growth
Request Sample Report
$ X Billion USD
